相似文献
1
Multi-platform 'Omics Analysis of Human Ebola Virus Disease Pathogenesis.
Cell Host Microbe. 2017 Dec 13;22(6):817-829.e8. doi: 10.1016/j.chom.2017.10.011. Epub 2017 Nov 16.
2
Plasma Proteomic Analysis Distinguishes Severity Outcomes of Human Ebola Virus Disease.
mBio. 2022 Jun 28;13(3):e0056722. doi: 10.1128/mbio.00567-22. Epub 2022 Apr 21.
3
Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea.
JCI Insight. 2017 Mar 23;2(6):e88864. doi: 10.1172/jci.insight.88864.
4
Avatar Mice Underscore the Role of the T Cell-Dendritic Cell Crosstalk in Ebola Virus Disease and Reveal Mechanisms of Protection in Survivors.
J Virol. 2022 Sep 28;96(18):e0057422. doi: 10.1128/jvi.00574-22. Epub 2022 Sep 8.
5
Unique human immune signature of Ebola virus disease in Guinea.
Nature. 2016 May 5;533(7601):100-4. doi: 10.1038/nature17949.
6
Early Human B Cell Response to Ebola Virus in Four U.S. Survivors of Infection.
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.01439-18. Print 2019 Apr 15.
7
Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection.
mBio. 2019 May 28;10(3):e00597-19. doi: 10.1128/mBio.00597-19.
8
Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease.
Clin Infect Dis. 2016 Aug 15;63(4):460-7. doi: 10.1093/cid/ciw334. Epub 2016 Jun 27.
9
Ebola Virus Disease Is Characterized by Poor Activation and Reduced Levels of Circulating CD16+ Monocytes.
J Infect Dis. 2016 Oct 15;214(suppl 3):S275-S280. doi: 10.1093/infdis/jiw260. Epub 2016 Aug 11.
10
Clinical Manifestations and Pathogenesis of Uveitis in Ebola Virus Disease Survivors.
Ocul Immunol Inflamm. 2018;26(7):1128-1134. doi: 10.1080/09273948.2018.1484493. Epub 2018 Jul 11.
引用本文的文献
1
Mass Spectrometry Imaging: Revolutionizing Molecular Insights in Infectious Diseases Research.
Pathogens. 2025 Jun 30;14(7):645. doi: 10.3390/pathogens14070645.
2
A systematic review of the immuno-inflammatory dysfunction secondary to viral hemorrhagic fevers; Ebola and Lassa fever.
PLoS Negl Trop Dis. 2025 Jun 25;19(6):e0013230. doi: 10.1371/journal.pntd.0013230. eCollection 2025 Jun.
3
Multi-platform omics analysis of Nipah virus infection reveals viral glycoprotein modulation of mitochondria.
Cell Rep. 2025 Mar 25;44(3):115411. doi: 10.1016/j.celrep.2025.115411. Epub 2025 Mar 17.
4
Proteomic profiling of peripheral blood mononuclear cells reveals immune dysregulation and metabolic alterations in kidney transplant recipients with COVID-19.
Front Immunol. 2024 Dec 16;15:1508110. doi: 10.3389/fimmu.2024.1508110. eCollection 2024.
5
Modular Polymerase Synthesis and Internal Protein Domain Swapping via Dual Opposed Frameshifts in the Ebola Virus L Gene.
Pathogens. 2024 Sep 25;13(10):829. doi: 10.3390/pathogens13100829.
6
Serum lipidome reveals lipid metabolic dysregulation in severe fever with thrombocytopenia syndrome.
BMC Med. 2024 Oct 14;22(1):458. doi: 10.1186/s12916-024-03672-w.
7
Pathogenic differences of cynomolgus macaques after Taï Forest virus infection depend on the viral stock propagation.
PLoS Pathog. 2024 Jun 11;20(6):e1012290. doi: 10.1371/journal.ppat.1012290. eCollection 2024 Jun.
8
A compendium of multi-omics data illuminating host responses to lethal human virus infections.
Sci Data. 2024 Apr 2;11(1):328. doi: 10.1038/s41597-024-03124-3.
9
Understanding COVID-19 progression with longitudinal peripheral blood mononuclear cell proteomics: Changes in the cellular proteome over time.
iScience. 2023 Sep 2;26(10):107824. doi: 10.1016/j.isci.2023.107824. eCollection 2023 Oct 20.
10
Brief review on ebola virus disease and one health approach.
Heliyon. 2023 Aug 8;9(8):e19036. doi: 10.1016/j.heliyon.2023.e19036. eCollection 2023 Aug.
本文引用的文献
1
Lipid testing in infectious diseases: possible role in diagnosis and prognosis.
Infection. 2017 Oct;45(5):575-588. doi: 10.1007/s15010-017-1022-3. Epub 2017 May 8.
2
Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease.
Sci Transl Med. 2017 Apr 12;9(385). doi: 10.1126/scitranslmed.aai9321.
3
Ebola Virus Disease, Democratic Republic of the Congo, 2014.
Emerg Infect Dis. 2016 Sep;22(9):1579-86. doi: 10.3201/eid2209.160354.
4
Ebola Virus Disease Is Characterized by Poor Activation and Reduced Levels of Circulating CD16+ Monocytes.
J Infect Dis. 2016 Oct 15;214(suppl 3):S275-S280. doi: 10.1093/infdis/jiw260. Epub 2016 Aug 11.
5
Ebola virus disease and critical illness.
Crit Care. 2016 Jul 29;20(1):217. doi: 10.1186/s13054-016-1325-2.
6
Unique human immune signature of Ebola virus disease in Guinea.
Nature. 2016 May 5;533(7601):100-4. doi: 10.1038/nature17949.
7
Multiscale Embedded Gene Co-expression Network Analysis.
PLoS Comput Biol. 2015 Nov 30;11(11):e1004574. doi: 10.1371/journal.pcbi.1004574. eCollection 2015 Nov.
8
Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus.
Nat Rev Microbiol. 2015 Nov;13(11):663-76. doi: 10.1038/nrmicro3524. Epub 2015 Oct 6.
9
Addressing the Complications of Ebola and Other Viral Hemorrhagic Fever Infections: Using Insights from Bacterial and Fungal Sepsis.
PLoS Pathog. 2015 Oct 1;11(10):e1005088. doi: 10.1371/journal.ppat.1005088. eCollection 2015 Oct.
10
Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study.
Lancet Infect Dis. 2015 Nov;15(11):1292-9. doi: 10.1016/S1473-3099(15)00144-9. Epub 2015 Aug 10.
Zotero 插件